Prix de ChainLink TokenLINK

Bull Run Target 🎯 $LINK $30 - $50

🧑‍💻 Top overall coins by notable development activity the past 30 days. #RAD #ICP #LINK

Grayscales Chainlink ETF has seen zero outflows since its debut, amassing $54.69 million in net inflows. Whale accumulation has also remained consistently strong. Despite these bullish indicators, LINKs price continues to decline. Analysts now point to several upcoming catalysts that could support the altcoins growth. Chainlink ETF Garners Sustained Institutional Attention BeInCrypto previously reported that the first-ever spot Chainlink ETF launched on December 2 on NYSE Arca. On its debut day, the fund recorded $37.05 million in inflows. Since then, it has not experienced a single outflow, although it recorded zero netflows on three separate trading days. According to data from SoSoValue, the ETF saw $2.02 million in net inflows on December 15. Notably, the funds cumulative inflows have now surpassed those of other altcoin ETFs, including Dogecoin and Litecoin products, despite those ETFs launching significantly earlier. Chainlink ETF Flows. Source: SoSoValue Meanwhile, demand for Bitcoin and Ethereum ETFs has weakened. On December 15, Bitcoin ETFs recorded $357.69 million in net outflows, while Ethereum ETFs saw $224.78 million exit the market. Against this backdrop, the Chainlink ETF continues to maintain a neutral to positive trajectory. In addition to ETF flows, on-chain data shows notable accumulation among Chainlinks largest holders. Analytics platform Santiment reported that the top 100 wallets have acquired 20.46 million LINK since November 1, worth approximately $263 million. This suggests strong conviction from investors. Top 100 Chainlink Wallets Accumulate LINK. Source: X/Santiment Analysts Outline Key Catalysts for LINK Despite Price Dip Nonetheless, LINKs price has yet to reflect this momentum. Data from BeInCrypto Markets shows that the altcoin has declined 11.1% over the past month. The downtrend extended further today, with LINK falling another 6% alongside a broader market sell-off. At the time of writing, the coin was trading at $12.78. Chainlink (LINK) Price Performance. Source: BeInCrypto Markets Market analysts have outlined several potential catalysts that could support Chainlinks price. Last week, the US Securities and Exchange Commission issued a no-action letter to the Depository Trust Company, approving a three-year pilot program to tokenize assets. While the blockchain protocols selected for the initiative have not yet been finalized, analysts believe Chainlink could emerge as a leading candidate, which would significantly strengthen its institutional use case. At the end of the day, ETH and LINK are the foundational backbone to the future of Quadrillions in on-chain trading volume tied to real world assets. If that core thesis reigns true, the simple solution is to buy these assets when they are cheap and wait, an analyst remarked. Tokenized assets ATH $LINK will be the obvious winner pic.twitter.com/nzxo9qE7pl Quinten | 048.eth (@QuintenFrancois) December 15, 2025 Additionally, in its 2026 market outlook, Grayscale highlighted that LINK could benefit from continued growth in stablecoins, asset tokenization, and decentralized finance applications. Thus, while LINKs price remains under pressure in the short term, sustained ETF inflows, strong whale accumulation, and growing institutional use cases suggest underlying demand remains intact. As asset tokenization and on-chain finance continue to evolve, these factors could likely play a key role in shaping Chainlinks next major price move. Read the article at BeInCrypto

Altseason never starts with noise. It always starts quietly. 2017 and 2021 followed the same path — patience first, explosion later. The current structure looks similar again. These are cycle-grade altcoins I’m watching before 2026: $LINK → $200–$400 $GRT → $10–$25 $ICP → $300–$600 #ZEN → $150–$350 #IMX → $20–$50 Not hype coins. Real infrastructure. Real adoption. Big money is built early — not at the top. Stay positioned, stay patient.